Needs Statement

This Emerging Topic Conference focuses on the basic, translational and clinical aspects of intrahepatic cholangiocarcinoma (iCCA). Emerging molecular technologies provide platforms to better unravel the molecular pathogenesis of iCCA, and the role of the tumor immune microenvironment. This conference will review these advances in pathogenesis iCCA, its clinical management and future challenges, with an emphasis on addressing unmet clinical needs.

Learning Objectives

Upon completion of this activity, learners will be able to:

• The conference will formulate a state-of-the-art review of recent research and treatment advances in iCCA, with particular emphasis on present and future and treatment opportunities;
• The conference will define and reconcile current areas of controversy;
• • The conference will delineate future avenues of research and highlight translational opportunities for novel therapies in iCCA.

Target Audience

• Hepatologists
• Gastroenterologists
• Nurses
• Nurse Practitioners
• Physician Assistants
• Transplant Coordinators
• Surgeons
• Fellows/Trainees
• Medical Oncologists

This activity was planned in the context of the following ACGME/IOM/IPEC competencies:

• Evidence-based Practice
• Medical Knowledge
• Interpersonal and Communication Skills
• Roles/Responsibilities
• Work in Interdisciplinary Teams

Submission Deadlines

• Opened: Wednesday, May 29, 2019 - ET
• Closed: Tuesday, August 20, 2019 - ET

Overview

Abstracts submitted will be reviewed by the Program Chairs for potential poster presentation. If selected, the presenting author will be required to accept the invitation to present, register for the conference, and provide current financial disclosure information.

Abstract notification will be sent to presenting authors by mid-August.

Questions

For questions about the abstract submission process, send an email to abstracts@aasld.org.

Press Policies and Guidelines

The American Association for the Study of Liver Diseases provides credentialed media with complimentary press registration. Below is information on eligibility and the credentialing process.

Press Eligibility

Journalists, and contributing freelancers, employed by a recognized news organization are eligible to apply for press registration. To be eligible for press registration, media in all categories must be directly involved in the creation of news content for organizations that meet these criteria:

• Publish original editorial news coverage in a regular news section
• Have complete editorial freedom from advertisers, funders and/or sponsors
• If sponsored, the outlet has multiple sponsors (no single-sponsored publications)
• Advertisers, sponsors, paid editorial and other funding sources are clearly identified

Bloggers

Bloggers will receive press credentials on a case-by-case basis. Please include a link to recent liver disease, hepatology or health care science coverage with your registration for credentials. Finally, all blogs must demonstrate the dissemination of original, editorial news coverage and editorial freedom from advertisers and/or sponsors (single-sponsored blogs will not receive credentials; blogs with advertising must have multiple advertisers clearly identified).

Photographers/Videographers

Photographers, videographers, and/or other members of the multimedia team accompanying credentialed news outlets may register as media and provide a link to recent coverage from their team. Further credentialing may be required during the approval process.

NOTE: AASLD has the right to inspect the credentials of anyone registering as media and reserves the right to deny media registration to anyone who does not meet the above guidelines. AASLD also has the right to limit the number of media registrants from any one media outlet to ensure ample space for all media.

Ineligible Registrants

The following individuals are not eligible for press registration or access to the Newsroom:

• Individuals who receive exhibitor passes
• Publishers or a publications’ advertising, marketing, public relations, sales, circulation, or any other non-editorial function representatives
• Industry/exhibitor press officers and their public relations consultants
• Financial or business analysts
• Educational program developers (including CME writers and editors)
• Trade media management personnel
• Editors, writers, and scientific advisory board members for journals that do not have editorial news sections
• Companies or organizations producing publications, videos, and/or other electronic media intended for internal use, marketing, advertising, financial analysis, or public relations purposes
• Media who produce a communications vehicle that is sponsored by a single organization or whose revenue for the publication or issue of a publication depends solely on coverage of 2019 AASLD Emerging Topic Conference, The Genomics Revolution: Changing Our Approach to Diagnostics, Management and Research in Adult and Pediatric Liver Disease
• Media who produce a communications vehicle that uses the AASLD’s name or logo, or the Emerging Topic Conference name/logo to imply endorsement from AASLD

NOTE: AASLD prohibits the development of CME content based on information presented at its meetings. CME writers and editors, and those writers and editors working on behalf of organizations that have written CME based on AASLD meetings, are not eligible for press passes.

Prohibited Activities

• Sales, marketing or representing a company for the purposes of obtaining advertising, subscriptions, selling photography/video production, or other products or services from any registrant or exhibitor
• Misrepresentation of role or activities to obtain media registration
• Developing or assisting in the development of continuing medical education programs
• Soliciting presenters and/or attendees for inclusion in CME programs
• Publishing or posting presentation slides, live streams of meeting presentations, or sharing copyrighted meeting materials without written permission.